Stay updated with breaking news from Macular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Post-hoc analyses from four phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in neovascular or ‘wet’ age-related macular degeneration and diabetic. | April 25, 2023 ....
‒ Post-hoc analyses from four Phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in wet age-related macular degeneration and diabetic macular edema . | April 25, 2023 ....
Post-hoc analyses from four Phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in wet age-related macular degeneration (AMD) and diabetic macular edema (DME) - More ....
- Wet age-related macular degeneration is a bilateral disease and incidence of neovascularization in the second eye is up to 42% in the first two to three years following diagnosis in the primary. | April 23, 2023 ....